Stephen Lam

Advisor at Nucleix

Dr. Stephen Lam is a Professor of Medicine at the University of British Columbia in Vancouver, Canada, a distinguished scientist, the Leon Judah Blackmore chair in lung cancer research, and MDS-Rix endowed director of translation lung cancer research at the BC Cancer Research Institute. He is the Medical Director of the Lung Cancer Screening Program in British Columbia. He chairs the IASLC Screening and Early Detection Committee and the Pan-Canadian Lung Cancer Screening Network of the Canadian Partnership Against Cancer. His research interest is in the risk-model-based approach to personalize lung cancer screening and chemoprevention. He was a recipient of the IASLC Joseph Cullen Award in lung cancer prevention research.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Nucleix

Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.


Industries

Headquarters

Na'an, Israel

Employees

51-200

Links